{"id":"https://openalex.org/W2137449223","doi":"https://doi.org/10.1200/jco.2011.38.6680","title":"Reply to J.W. Locasale et al","display_name":"Reply to J.W. Locasale et al","publication_year":2011,"publication_date":"2011-12-06","ids":{"openalex":"https://openalex.org/W2137449223","doi":"https://doi.org/10.1200/jco.2011.38.6680","mag":"2137449223"},"language":"fr","primary_location":{"id":"doi:10.1200/jco.2011.38.6680","doi":"https://doi.org/10.1200/jco.2011.38.6680","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2011.38.6680","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.6680?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.6680?role=tab","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055183757","display_name":"John de Groot","orcid":"https://orcid.org/0000-0003-1454-6461","observed_orcids":["https://orcid.org/0000-0003-1454-6461"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. de Groot","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX","Neuro-Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Neuro-Oncology","institution_ids":["https://openalex.org/I4210102457"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079081497","display_name":"Amy B. Heimberger","orcid":"https://orcid.org/0000-0002-9970-8695","observed_orcids":["https://orcid.org/0000-0002-9970-8695"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Heimberger","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX","Neurosurgery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Neurosurgery","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046264008","display_name":"Michael D. Prados","orcid":"https://orcid.org/0000-0002-9630-2075","observed_orcids":["https://orcid.org/0000-0002-9630-2075"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Prados","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021656597","display_name":"Patrick Yung Wen","orcid":"https://orcid.org/0000-0002-0774-7700","observed_orcids":["https://orcid.org/0000-0002-0774-7700","https://orcid.org/0000-0003-3224-3042","https://orcid.org/0000-0002-2452-0540"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Y. Wen","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"3","first_page":"338","last_page":"339"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7240999937057495,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7240999937057495,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.1898999959230423,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.8730000257492065},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9879999756813049},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy-resistance","display_name":"anti-angiogenic therapy resistance","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.7889999747276306},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-1alpha","display_name":"hypoxia-inducible factor-1\u03b1","score":0.8870000243186951},{"id":"https://openalex.org/keywords/carbonic-anhydrase-ix","display_name":"carbonic anhydrase IX","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.9940000176429749},{"id":"https://openalex.org/keywords/stat3","display_name":"STAT3","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8889999985694885},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9309999942779541},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.953000009059906},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.6150000095367432},{"id":"https://openalex.org/keywords/glioblastoma-stem-cells","display_name":"glioblastoma stem cells","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7564334869384766},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6963198184967041},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.6563599705696106},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6316821575164795},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5849182605743408},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.5764905214309692},{"id":"https://openalex.org/C7876069","wikidata":"https://www.wikidata.org/wiki/Q14873666","display_name":"Paracrine signalling","level":3,"score":0.5659857392311096},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.5373996496200562},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.47522619366645813},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4497235119342804},{"id":"https://openalex.org/C129470790","wikidata":"https://www.wikidata.org/wiki/Q415718","display_name":"CXCR4","level":4,"score":0.4282182455062866},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.4269111156463623},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.33455294370651245},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3017762303352356},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.293818861246109},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2818690836429596},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.266937792301178},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.22454646229743958},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18731394410133362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1850517988204956},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14626818895339966},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.10943955183029175},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.07761666178703308},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2011.38.6680","doi":"https://doi.org/10.1200/jco.2011.38.6680","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2011.38.6680","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.6680?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3269956","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3269956","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1200/jco.2011.38.6680","doi":"https://doi.org/10.1200/jco.2011.38.6680","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2011.38.6680","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.6680?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2137449223.pdf","grobid_xml":"https://content.openalex.org/works/W2137449223.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W2017322644","https://openalex.org/W2062165914","https://openalex.org/W2072954179","https://openalex.org/W2092409918","https://openalex.org/W2102182216","https://openalex.org/W2113472355","https://openalex.org/W2120682723","https://openalex.org/W2125521995","https://openalex.org/W2142644858","https://openalex.org/W2148131374","https://openalex.org/W2161190434","https://openalex.org/W2783142245"],"related_works":["https://openalex.org/W2587124544","https://openalex.org/W7100755300","https://openalex.org/W3005972494","https://openalex.org/W2111336617","https://openalex.org/W2737528326","https://openalex.org/W2982924140","https://openalex.org/W2728003117","https://openalex.org/W2591697035","https://openalex.org/W4395040212","https://openalex.org/W2170273827"],"abstract_inverted_index":{"We":[0],"appreciate":[1],"the":[2,10,112,134,155,161,186,205,238,306,431,445],"thoughtful":[3],"comments":[4],"by":[5,295],"Locasale":[6,75],"et":[7,76],"al1":[8],"regarding":[9],"tumor":[11,33,135,156,162,184,192,215,228,387,417],"biomarker":[12,421],"analysis":[13,29,346,394,415],"from":[14,183,385,440],"our":[15,345,441],"recent":[16,323],"phase":[17],"II":[18],"clinical":[19],"trial":[20,442],"of":[21,35,46,105,123,204,241,308,352,367,380,395,416,430,434,448,452,461],"aflibercept":[22],"for":[23,315],"recurrent":[24],"glioblastoma":[25,266],"(NABTC":[26],"06-01).2":[27],"Our":[28],"demonstrated":[30,237,326],"that":[31,79,115,327,348],"elevated":[32,59],"levels":[34],"hypoxia-inducible":[36,88],"factor":[37,89,175],"1\u03b1":[38,90],"and":[39,103,118,136,142,158,210,219,229,248,251,261,282,305,331,339,360,400,419,436,455,463],"carbonic":[40],"anhydrase":[41],"9":[42],"(CA9),":[43],"both":[44,116,140,150,227],"markers":[45,351],"hypoxia,":[47],"were":[48,61,362],"strongly":[49,109],"correlated":[50],"with":[51,58,111,342],"patient":[52],"response":[53,435],"to":[54,64,71,125,171,201,213,290,364,425],"aflibercept,":[55],"whereas":[56],"patients":[57],"CXCR4":[60,73,92,117,141,190,260,462],"more":[62],"likely":[63],"be":[65,82,145,383],"resistant.":[66],"Because":[67],"hypoxia":[68,328],"is":[69,129,221,423],"known":[70,179],"induce":[72],"expression,":[74],"al":[77],"suggest":[78],"there":[80],"may":[81,144,287,301],"a":[83,130,165,222,368,427],"positive":[84,369],"feedback":[85,370],"loop":[86,371],"whereby":[87],"induces":[91,332],"expression":[93,304,397],"in":[94,98,147,168,194,226,243,252,265,407],"resistant":[95,363],"tumors,":[96],"which":[97,286,312,335],"turn":[99],"activates":[100],"signal":[101],"transducer":[102],"activator":[104],"transcription":[106],"3":[107,207],"(STAT3).\r\n\r\nWe":[108],"agree":[110],"authors'":[113],"conclusions":[114],"STAT3":[119,143,242,262],"represent":[120],"potential":[121,432],"mediators":[122],"resistance":[124,170,289,457],"antiangiogenic":[126,299,453],"therapy.":[127,176],"There":[128],"complex":[131],"interaction":[132],"between":[133],"its":[137],"microenvironment,":[138,157],"where":[139],"expressed":[146,264,271],"either":[148],"or":[149,185,197,297],"compartments.":[151],"Antiangiogenic":[152],"therapy":[153,300,403],"targets":[154],"not":[159],"surprisingly,":[160],"microenvironment":[163,187],"plays":[164],"central":[166,223,239],"role":[167,240],"mediating":[169,316],"anti\u2013vascular":[172],"endothelial":[173,318],"growth":[174,319],"CXCL12":[177,303],"(formerly":[178],"as":[180,356],"SDF-1\u03b1)":[181],"elaborated":[182],"can":[188],"activate":[189],"on":[191,255,272],"cells":[193],"an":[195],"autocrine":[196],"paracrine":[198],"fashion,":[199],"leading":[200],"downstream":[202],"activation":[203],"phosphoinositide":[206],"kinase/AKT,":[208],"STAT3,":[209],"MAPK":[211],"pathways":[212],"promote":[214,336],"survival,":[216],"angiogenesis,":[217,247],"metastasis,":[218],"invasion.3\r\n\r\nSTAT3":[220],"signaling":[224],"node":[225],"infiltrating":[230],"immune":[231,249,337],"cells.4":[232],"Preclinical":[233],"studies":[234,324],"have":[235,325],"recently":[236],"regulating":[244],"glioma":[245,256],"proliferation,":[246],"evasion":[250],"prosurvival":[253],"effects":[254],"stem":[257],"cells.5\u20137":[258],"Although":[259],"are":[263,269,313],"cells,":[267,281,285],"they":[268],"also":[270,329],"multiple":[273],"myeloid":[274,310],"cell":[275],"types":[276],"including":[277,459],"monocytes/macropahges,":[278],"granulocytes,":[279],"dendritic":[280],"myeloid-derived":[283],"suppressor":[284],"mediate":[288],"antianigogenic":[291],"therapy.8,9":[292],"Hypoxia":[293],"exacerbated":[294],"prolonged":[296],"high-dose":[298],"increase":[302],"attraction":[307],"CXCR4+":[309],"cells,10":[311],"responsible":[314],"vascular":[317],"factor\u2013independent":[320],"angiogenesis.":[321],"Interestingly,":[322],"attracts":[330],"regulatory":[333],"T-cells,":[334],"tolerance":[338],"angiogenesis.11,12":[340],"Consistent":[341],"this":[343,378],"idea,":[344],"showed":[347],"tumors":[349,410],"expressing":[350],"lymphocyte":[353],"proliferation":[354],"such":[355],"CXCR4,":[357],"CD84,":[358],"ZAP70,":[359],"CD27":[361],"aflibercept.":[365],"Characterization":[366],"will":[372,392,443],"ultimately":[373],"require":[374,393],"additional":[375],"studies,":[376],"because":[377,409],"level":[379],"complexity":[381],"cannot":[382],"gleaned":[384],"undissected":[386],"tissue":[388,418],"analysis;":[389],"rather,":[390],"it":[391],"gene":[396],"after":[398],"microdissection":[399],"preclinical":[401],"studies.\r\n\r\nAntiangiogenic":[402],"has":[404],"limited":[405],"efficacy":[406],"glioblastoma,":[408],"rapidly":[411],"develop":[412,426],"resistance.":[413,437],"Careful":[414],"blood":[420],"data":[422,439],"critical":[424],"full":[428],"understanding":[429],"mechanisms":[433],"The":[438],"inform":[444],"next":[446],"generation":[447],"trials":[449],"using":[450],"combinations":[451],"agents":[454],"targeting":[456],"pathways,":[458],"inhibitors":[460],"STAT3.":[464]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}